Come up with a name for your new list and we'll add to it:
amcure raised a round of funding on August 31, 2017. Investors include
Bundesministerium fur Bildung und Forschung.
amcure is a spin-off from the Karlsruhe Institute of Technology established in 2012. The company develops peptide active ingredients for the treatment of highly metastatic carcinomas. The first of the…